CAH vs NUS
Cardinal Health Inc. and NU Skin Enterprises, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CAH | NUS |
|---|---|---|
| Revenue | $254.2B | $1.5B |
| Net income | $1.7B | $160.2M |
| Gross margin | 3.8% | 69.4% |
| Net margin | 0.7% | 10.8% |
| Return on equity | · | 22.0% |
| Diluted EPS | $7.23 | $3.18 |
| Dividend / share | $2.04 | · |
| Payout ratio | 28.6% | 7.4% |
| Free cash flow | $4.5B | $46.0M |
| Equity | $-2.9B | $805.2M |
| Net debt / equity | · | −0.02× |
| Current ratio | 0.88× | 2.08× |
| Revenue CAGR 5y | 9.4% | −10.5% |
| Profit CAGR 5y | 22.9% | −3.5% |
CAH bills 171.2× the revenue of NUS, and NUS keeps more of each dollar of revenue as profit (10.8% against 0.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CAH | NUS |
|---|---|---|
| FY2025 | $254.2B | $1.5B |
| FY2024 | $222.6B | $1.7B |
| FY2023 | $226.8B | $2.0B |
| FY2022 | $205.0B | $2.2B |
| FY2021 | $181.3B | $2.7B |
| FY2020 | $162.5B | $2.6B |
| FY2019 | $152.9B | $2.4B |
| FY2018 | $145.5B | $2.7B |
| FY2017 | $136.8B | $2.3B |
| FY2016 | $130.0B | $2.2B |
Bottom line
| Fiscal year | CAH | NUS |
|---|---|---|
| FY2025 | $1.7B | $160.2M |
| FY2024 | $1.6B | $-146.6M |
| FY2023 | $852.0M | $8.6M |
| FY2022 | $330.0M | $104.8M |
| FY2021 | $-938.0M | $147.3M |
| FY2020 | $611.0M | $191.4M |
| FY2019 | $-3.7B | $173.6M |
| FY2018 | $1.4B | $121.9M |
| FY2017 | $256.0M | $129.4M |
| FY2016 | $1.3B | $143.1M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$252,762,841,000 | CAH |
| FY2024 | +$220,845,916,000 | CAH |
| FY2023 | +$224,857,869,000 | CAH |
| FY2022 | +$202,753,341,000 | CAH |
| FY2021 | +$178,630,331,000 | CAH |
| FY2020 | +$159,885,066,000 | CAH |
| FY2019 | +$150,501,584,000 | CAH |
| FY2018 | +$142,854,992,000 | CAH |
| FY2017 | +$134,529,901,000 | CAH |
| FY2016 | +$127,768,203,000 | CAH |
| FY2015 | +$119,298,953,000 | CAH |
| FY2014 | +$99,961,505,000 | CAH |
| FY2013 | +$87,907,282,000 | CAH |
| FY2012 | +$98,960,743,000 | CAH |
| FY2011 | +$105,832,412,000 | CAH |
| FY2010 | +$101,106,741,000 | CAH |
| FY2009 | +$97,171,942,000 | CAH |
CAH has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −10.1 pp | NUS |
| FY2024 | +9.2 pp | CAH |
| FY2023 | −0.1 pp | NUS |
| FY2022 | −4.5 pp | NUS |
| FY2021 | −6.0 pp | NUS |
| FY2020 | −7.0 pp | NUS |
| FY2019 | −9.6 pp | NUS |
| FY2018 | −3.6 pp | NUS |
| FY2017 | −5.5 pp | NUS |
| FY2016 | −5.5 pp | NUS |
| FY2015 | −4.7 pp | NUS |
| FY2014 | −6.2 pp | NUS |
| FY2013 | −10.2 pp | NUS |
| FY2012 | −10.1 pp | NUS |
| FY2011 | −7.9 pp | NUS |
| FY2010 | −7.9 pp | NUS |
| FY2009 | −6.1 pp | NUS |
The higher net margin has changed hands between CAH and NUS over this period.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NUS's net margin has been more volatile than CAH's over the 17 comparable fiscal years — 4.5 percentage points of standard deviation against 0.9.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CAH and NUS over these 17 fiscal years — CAH led in 1 and NUS in 16.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CAH's return on equity has been more volatile than NUS's over the 13 comparable fiscal years — 29.7 percentage points of standard deviation against 9.6.
13 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CAH and NUS over these 13 fiscal years — CAH led in 4 and NUS in 9.
13 of 19 comparable fiscal years — a year missing data on either side is not counted.